Clinical Trial Update: Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Apitegromab for overweight or obesity has completed, with results reported on its efficacy and safety in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Apitegromab (SRK-015)

Snippet

Sponsor: Scholar Rock, Inc. | Conditions: Overweight and Obesity | Phase 2 | Status: COMPLETED